Stem cell therapy trial reverses "irreversible" damage to cornea
SMRTR summary
A new stem cell treatment called CALEC has shown promise in repairing damaged corneas and restoring vision in patients with severe eye injuries. In a clinical trial, 79% of participants had their corneas fully restored after 12 months, with 92% achieving at least partial success and most regaining some sight.
SMRTR provides this summary for quick context. The original article belongs to Hacker News.
Read the original article